Nikhilesh Tiwari

Nikhilesh Tiwari

Active Director Director DIN 02920917
DIN 02920917 First appointment Apr 2010 Primary industry E-Commerce
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 2010
Shareholding value •••• Premium profile

About Nikhilesh Tiwari

Data last updated:

Nikhilesh Tiwari is a Director at Collateral Medical Private Limited (since 2010), Director at Colmed Innovations Private Limited (since 2021) and Director at Colmed Health Tech Private Limited (since 2024). The companies operate in E-Commerce, Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹31.28 Cr; the largest is Collateral Medical Private Limited at ₹20.65 Cr (FY 2025). Earlier, Nikhilesh Tiwari was a Director at Donnamed Healthcare Private Limited (2017–2018) and Designated Partner at Donnamed Healthcare Llp (from 2018).

DIN 02920917
Primary Designation Director
Industry E-Commerce
First Appointment 12 Apr 2010
Oldest Company Age 16 yrs
Largest company Collateral Medical Private Limited · ₹20.65 Cr (FY 2025)
Combined revenue ₹31.28 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Collateral Medical Private Limited U33100MH2010PTC201959
Director12 Apr 20102010₹20.65 Cr (FY 2025)Active
Colmed Innovations Private Limited U33112MH2021PTC371036
Director08 Nov 20212021₹10.63 Cr (FY 2025)Active
Colmed Health Tech Private Limited U32509MH2024PTC435388
Director25 Nov 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Donnamed Healthcare Private Limited U74999DL2017PTC319629
Director23 Jun 20172017Converted To Llp
Designated Partner25 Aug 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Collateral Medical Private Limited
Colmed Innovations Private Limited
Donnamed Healthcare Llp
Colmed Health Tech Private Limited
Premium access

Shareholding and investment profile for Nikhilesh Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikhilesh Tiwari

Nikhilesh Tiwari currently holds 3 directorships: Collateral Medical Private Limited (Director, since 12 Apr 2010, revenue ₹20.65 Cr (FY 2025)); Colmed Innovations Private Limited (Director, since 08 Nov 2021, revenue ₹10.63 Cr (FY 2025)); Colmed Health Tech Private Limited (Director, since 25 Nov 2024).

Nikhilesh Tiwari was first appointed on 12 Apr 2010 as Director at Collateral Medical Private Limited. The most recent appointment on record is 25 Nov 2024 at Colmed Health Tech Private Limited.

The 2 current companies of Nikhilesh Tiwari that report revenue have a combined latest revenue of ₹31.28 Cr: Collateral Medical Private Limited ₹20.65 Cr (FY 2025); Colmed Innovations Private Limited ₹10.63 Cr (FY 2025).

Nikhilesh Tiwari held 2 earlier board appointments: Donnamed Healthcare Private Limited (Director, 23 Jun 2017 to 24 Aug 2018); Donnamed Healthcare Llp (Designated Partner, from 25 Aug 2018).

The current boards of Nikhilesh Tiwari's companies include Hithendra Karadathodi Ramachandran (Collateral Medical Private Limited), Nishant Beniwal (Collateral Medical Private Limited), Sarika Saxena (Collateral Medical Private Limited), Saurabh Pandey (Collateral Medical Private Limited), Ilayaraja Ganesan (Colmed Innovations Private Limited), Parag Pramod Sheth (Colmed Health Tech Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available